COVID-19 vaccination in patients with rheumatic diseases leads to a high seroconversion rate and reduced self-imposed isolation and shielding behaviour
Sign Up to like & getrecommendations! Published in 2022 at "Modern Rheumatology"
DOI: 10.1093/mr/roac069
Abstract: ABSTRACT Objectives We investigated the effect of a two-dose messenger ribonucleic acid (mRNA) vaccine on antibody levels against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and patient behaviour and shielding concerning fear of coronavirus disease… read more here.
Keywords: high seroconversion; vaccination; vaccination patients; reduced self ... See more keywords
John Cunningham Virus Status, Seroconversion Rate, and the Risk of Progressive Multifocal Leukoencephalopathy in Polish John Cunningham Virus-Seronegative Patients with Relapsing-Remitting Multiple Sclerosis
Sign Up to like & getrecommendations! Published in 2020 at "European Neurology"
DOI: 10.1159/000510849
Abstract: Introduction: Presence of anti-JC-virus antibodies (JCVAbs) is associated with the increased risk of natalizumab (NAT)-related progressive multifocal leukoencephalopathy (PML). Little is known about seroconversion rate and time to seroconversion in relapsing-remitting multiple sclerosis (RRMS) patients… read more here.
Keywords: john cunningham; cunningham virus; seroconversion; seroconversion rate ... See more keywords
Antibody response to mRNA vaccination for COVID-19 in patients with AML receiving hypomethylating agents alone or with venetoclax
Sign Up to like & getrecommendations! Published in 2022 at "Blood Advances"
DOI: 10.1182/bloodadvances.2021006949
Abstract: Patients with acute myeloid leukemia (AML) and myelodysplastic syndromes (MDSs) who are treated with hypomethylating agents (HMAs), alone or in combination with venetoclax, are an extremely vulnerable population due to advanced age, comorbidities, and treatment-induced… read more here.
Keywords: vaccination; leukemia; hypomethylating agents; seroconversion rate ... See more keywords